NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. Hempsana Holdings Ltd. today announced that it has entered into a custom manufacturing agreement with Cream of the Crop Therapeutics to launch their Terpene Rich TM formulated product. Under the terms of the agreement, Hempsana has ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.

Hempsana Holdings Ltd. (the " Company " or " Hempsana "), today announced that it has entered into a custom manufacturing agreement with Cream of the Crop Therapeutics (" Cream of the Crop "), to launch their Terpene Rich TM formulated product.

Under the terms of the agreement, Hempsana has agreed to exclusively manufacture Cream of the Crop's Terpene Rich TM Relief Cream. Hempsana will be responsible for providing high-quality cannabis extracts, filling, packaging, and manufacturing services. A predetermined wholesale price will be earned as a fee by Hempsana for the manufacturing, shipping, and sale of the product; in addition, a brokerage fee will be earned on monthly revenue. Cream of the Crop will receive revenue upon the sale of products to the various provincial cannabis regulators.

Cream of the Crop Therapeutics is an Ontario-based boutique brand focused on cannabis products that focuses on enhancing the lives of others by using cannabinoids and other plant components in Terpene Rich TM formulations, with novel delivery systems and robust IP.

Cream of the Crop's Terpene Rich TM Relief Cream is the lead product forming a platform for a robust product line and relatable cannabis information and education.

"We are humbled to be the exclusive partner of Cream of the Crop Therapeutics to launch their top selling product." said Randy Ko, CEO of Hempsana. "We are especially excited about exposing the benefits of this wonderful product to the patients nationally through the medical sales channel which we believe is an underserved area in the sector."

"We are excited to partner with Randy and his team at Hempsana who share our values and goals of providing premium products that prevent, relieve, and heal." said Clive Webb, President of Cream of the Crop.

About Hempsana Holdings Ltd.

The Company's business involves the manufacturing of major and minor cannabinoid derivatives and producing cannabis extracts for use in finished products, including topical creams, vape pens and other infused consumables. Hempsana's Health Canada Standard Processing Licensed, and EU-GMP compliant facility provides the Company with access to wholesale and retail channels in Canada and internationally. Hempsana currently offers a wide range of product formats, including topicals, tinctures, salves, vape pens which can all be fortified with major and minor cannabinoids that are all manufactured by Hempsana.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements and forward-looking information within the meaning of applicable Canadian and U.S. securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. More particularly and without limitation, this press release contains forward looking statements and information concerning the business and operations of the Company. The forward-looking statements and information are based on certain key expectations and assumptions made by management, including expectations and assumptions concerning the Company. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information. There can be no assurance that they will prove to be correct. By its nature, such forward-looking information is subject to various risks and uncertainties, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed. These risks and uncertainties, include, but are not limited to, general economic conditions and the state of the regulatory environment. Please refer to the Company's public record on SEDAR at www.sedar.com for more details on the risks faced by the Company. Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date hereof, and to not use such forward- looking information for anything other than its intended purpose. Management of the Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Randy Ko
Director and Chief Executive Officer
T: (647) 255-8849P
E: randy@hempsana.ca

News Provided by Business Wire via QuoteMedia

Cronos Group Provides Bi-Weekly MCTO Status Update

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group" or the "Company") is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 Management Cease Trade Orders (" NP 12-203 ").

On November 9, 2021, the Company announced that it applied for a management cease trade order (" MCTO ") with the applicable securities regulatory authorities in Canada on the basis that the Company would be unable to file its Quarterly Report on Form 10-Q for the period ended September 30, 2021 (the " Form 10-Q ") with the U.S. Securities and Exchange Commission (the " SEC "), together with its corresponding quarterly filings in Canada (collectively, the " Required Filings "), by the applicable filing deadlines (the " Original Announcement "). The MCTO was issued on November 16, 2021 and restricts all trading in securities of the Company, whether direct or indirect, by the Chief Executive Officer and Chief Financial Officer of the Company until two full business days following the filing of the Required Filings and the MCTO has been revoked. The MCTO does not affect the ability of other shareholders of the Company to trade their securities.

Keep reading... Show less
Gage Growth Corp. Announces DTC Eligibility and Closing of Sturgis Dispensary

Gage Growth Corp. Announces DTC Eligibility and Closing of Sturgis Dispensary

Gage Growth Corp. ("Gage" or the "Company") (CSE: GAGE) (OTCQX: GAEGF), a leading high-quality cannabis premium brand and operator in Michigan is pleased to announce that its subordinate voting shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company ("DTC") and can now be both traded and serviced through DTC's electronic book-entry system.

Keep reading... Show less
The Power Play by the Market Herald Releases New Interviews With Lumiera, Fsd Pharma, HydroGraph, and Adastra Holdings

The Power Play by the Market Herald Releases New Interviews With Lumiera, Fsd Pharma, HydroGraph, and Adastra Holdings

The Power Play by The Market Herald has announced the release of new interviews with Lumiera, FSD Pharma, HydroGraph, and Adastra Holdings discussing their latest press releases

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Keep reading... Show less
AgriFORCE

AgriFORCE Signs Definitive Contract to Deploy Its Proprietary Grow House Facility and IP in Barbados for Production of High Value Medical and Agricultural Crops

AgriFORCE Growing Systems Ltd. (“the Company") (NASDAQ: AGRI; AGRIW), an Intellectual Property (IP) -focused AgTech company dedicated to advancing sustainable cultivation and crop processing across multiple platforms, has signed a definitive contract with Humboldt Bliss, Ltd. (“Humboldt”), an agriculture and aquaculture business based in Barbados, West Indies. The contract is for the deployment of the AgriFORCE foundational IP – which includes a proprietary facility design, production and operation technologies and methods, and an automated growing system (the AgriFORCE “Grow House”) for the cultivation and sale of high value medical and agricultural products into the Caribbean and global pharmaceutical and agricultural markets.

Keep reading... Show less
Ayurcann Wins Two Leading Awards in Canada for Extraction Facility and Toll Processing Facility of the Year

Ayurcann Wins Two Leading Awards in Canada for Extraction Facility and Toll Processing Facility of the Year

Ayurcann Holdings Corp. ( CSE: AYUR OTCQB: CDCLF FSE:3ZQ0 ) (the "Company" or "Ayurcann") a Canadian cannabis extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to announce that it has won Extraction Facility of the Year and Toll Processing Facility of the Year at the 2021 GrowUp Awards Gala in Niagara Falls, Ontario, Canada.

Ayurcann is a growing extraction company continuously incorporating new and strategic business approaches to maintain their industry leading services. With an annual extraction capacity of up to 300,000 kg, Ayurcann can supply bulk or formulated THC and CBD products to industry leaders while also offering a competitive advantage through their white labelling services.

Keep reading... Show less
Adastra Holdings Reports Record Third Quarter Results

Adastra Holdings Reports Record Third Quarter Results

 Adastra Holdings Ltd. (CSE: XTRX) (FRA: D2EP) ("Adastra" or the "Company") has today filed its consolidated financial statements and related management discussion and analysis for the three and nine months ended September 30, 2021 and 2020, both of which are available at www.sedar.com .

Keep reading... Show less

Top News

Related News